Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bazedoxifene Dose-Response in Japanese Osteoporosis
NCT00238745Phase 2Completed
- Sponsor
- Pfizer
- Start
- Aug 2003
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of bazedoxifene in postmenopausal osteoporosis, sponsored by Pfizer. Started Aug 2003; status: completed.
02
Drugs
bazedoxifene
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00238745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00238745.